Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 59

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 59
---
 Direct Registration System
In the deposit agreement, all parties to the deposit agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon acceptance thereof to DRS by DTC. DRS is the system administered by DTC pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. Profile is a required feature of DRS which allows a DTC participant, claiming to act on behalf of an ADS holder, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register such transfer.

<div align='center'>39</div>

TABLE OF CONTENTS

### TAXATION

#### U.S. Federal Income Tax Considerations
Our most recent Annual Report on Form 20-F, as updated by other reports and documents we file with the SEC, provides a discussion of the material U.S. federal income tax considerations that may be relevant to prospective investors in certain of our securities.

#### Non-U.S. Tax Considerations
Our most recent Annual Report on Form 20-F, as updated by other reports and documents we file with the SEC, provides a discussion of the material Cayman Islands tax consequences that may be relevant to prospective investors in our securities.

<div align='center'>40</div>

TABLE OF CONTENTS

SELLING SHAREHOLDERS This prospectus relates to the offer and resale from time to time by the Selling Shareholders of (i) up to 1,953,124 of our ADSs representing 1,953,124 of our ordinary shares and (ii) up to 1,953,124 of our ADSs representing 1,953,124 ordinary shares issuable upon the exercise of the Warrants. When we refer to the “Selling Shareholders” in this prospectus, we are referring to the persons listed in the table below, and the pledgees, donees, permitted transferees, assignees, successors, and others who later come to hold any of the Selling Shareholder’s interests in our securities other than through a public sale. The table below sets forth the name of the Selling Shareholders that beneficially owns our ADSs and the underlying ordinary shares represented by ADSs upon the exercise of the Warrants. The